People: Synergy Pharmaceuticals Inc (SGYP.O)

SGYP.O on Nasdaq

29 Jul 2014
Price Change (% chg)

$0.12 (+3.31%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Cerrone, Gabriele 

Brief Biography

Mr. Gabriele M. Cerrone serves as the Chairman of the Board of Synergy Pharmaceuticals Inc., since July 2008. From March 1999 to January 2005 Mr. Cerrone served as a Senior Vice President of Investments of Oppenheimer & Co. Inc., a financial services firm. In May 2001, Mr. Cerrone led the restructuring of SIGA Technologies, Inc., a biotechnology company, and served on its board of directors from May 2001 to May 2003. Mr. Cerrone co-founded Trovagene, Inc. (formerly Xenomics, Inc.), a diagnostics company, and served as Co-Chairman from July 2005 until November 2006. Mr. Cerrone co-founded FermaVir Pharmaceuticals, Inc., a biotechnology company, and served as Chairman from August 2005 to September 2007, when the company was acquired by Inhibitex, Inc., a biotechnology company. Mr. Cerrone served as a director of Inhibitex, Inc. from September 2007 until February 2012 when it was acquired by Bristol-Myers Squibb Company. Mr. Cerrone serves as a director of Trovagene, Inc. Mr. Cerrone is the managing partner of Panetta Partners Ltd., a private investor in both public and private venture capital in the life sciences and technology arena as well as real estate. Mr. Cerrone’s experience in finance and investment banking allows him to contribute broad financial and strategic planning experience and led to the Board’s conclusion that he should serve as a director of the company.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
499,375 -- 240,536 739,911

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gabriele Cerrone


Gary Jacob


Bernard Denoyer


Paul Eng


Marino Garcia


Kunwar Shailubhai

As Of 30 Dec 2013
Search Stocks